References
1 Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
2 Slezak R, Smigiel R, Rydzanicz M, et al. Phenotypic expansion in Zhu-Tokita-Takenouchi-Kim syndrome caused by de novo variants in the SON gene[J]. Mol Genet Genomic Med, 2020, 8(10): e1432. PMID: 32705777. PMCID: PMC7549597. DOI: 10.1002/mgg3.1432.
3 Stark Z, Tan TY, Chong B, et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders[J]. Genet Med, 2016, 18(11): 1090-1096. PMID: 26938784. DOI: 10.1038/gim.2016.1.
4 Kim JH, Shinde DN, Reijnders MRF, et al. De novo mutations in SON disrupt RNA splicing of genes essential for brain development and metabolism, causing an intellectual-disability syndrome[J]. Am J Hum Genet, 2016, 99(3): 711-719. PMID: 27545680. PMCID: PMC5011044. DOI: 10.1016/j.ajhg.2016.06.029.
5 Quintana Castanedo L, Sánchez Orta A, Maseda Pedrero R, et al. Skin and nails abnormalities in a patient with ZTTK syndrome and a de novo mutation in SON[J]. Pediatr Dermatol, 2020, 37(3): 517-519. PMID: 32045494. DOI: 10.1111/pde.14113.
6 Ahn EY, DeKelver RC, Lo MC, et al. SON controls cell-cycle progression by coordinated regulation of RNA splicing[J]. Mol Cell, 2011, 42(2): 185-198. PMID: 21504830. PMCID: PMC3137374. DOI: 10.1016/j.molcel.2011.03.014.
7 Zhu X, Petrovski S, Xie P, et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios[J]. Genet Med, 2015, 17(10): 774-781. PMID: 25590979. PMCID: PMC4791490. DOI: 10.1038/gim.2014.191.
8 Tokita MJ, Braxton AA, Shao Y, et al. De novo truncating variants in SON cause intellectual disability, congenital malformations, and failure to thrive[J]. Am J Hum Genet, 2016, 99(3): 720-727. PMID: 27545676. PMCID: PMC5011061. DOI: 10.1016/j.ajhg.2016.06.035.
9 Takenouchi T, Miura K, Uehara T, et al. Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: possible contribution to Braddock-Carey syndrome phenotype[J]. Am J Med Genet A, 2016, 170(10): 2587-2590. PMID: 27256762. DOI: 10.1002/ajmg.a.37761.
10 辛红美, 赵建设, 律玉强, 等. 一例 SON基因杂合变异所致ZTTK综合征患儿的临床及遗传学分析 [J]. 中华医学遗传学杂志, 2022, 39(3): 316-320. PMID: 35315044. DOI: 10.3760/cma.j.cn511374-20210315-00225.
11 Pasca L, Politano D, Cavallini A, et al. A novel de novo heterozygous mutation in the SON gene associated with septo-optic dysplasia: a new phenotype[J]. Neuropediatrics, 2024, 55(3): 191-195. PMID: 37343586. DOI: 10.1055/a-2114-4387.
12 El-Said A, Morales JL, Rossi G, et al. Metabolic stroke as a clinical manifestation of Zhu-Tokita-Takenouchi-Kim syndrome: a case series[J]. Neurol Genet, 2023, 9(3): e200072. PMID: 37168776. PMCID: PMC10166595. DOI: 10.1212/NXG.0000000000200072.
13 Langford J, Vukadin L, Carey JC, et al. SON-related Zhu-Tokita-Takenouchi-Kim syndrome with recurrent hemiplegic migraine: putative role of PRRT2[J]. Neurol Genet, 2023, 9(3): e200062. PMID: 37057295. PMCID: PMC10091367. DOI: 10.1212/NXG.0000000000200062.
14 Tang S, You J, Liu L, et al. Expanding the mutational spectrum of ZTTK syndrome: a de novo variant with global developmental delay and malnutrition in a Chinese patient[J]. Mol Genet Genomic Med, 2023, 11(8): e2188. PMID: 37488749. PMCID: PMC10422072. DOI: 10.1002/mgg3.2188.
15 Yang L, Yang F. A de novo heterozygous variant in the SON gene is associated with Zhu-Tokita-Takenouchi-Kim syndrome[J]. Mol Genet Genomic Med, 2020, 8(11): e1496. PMID: 32926520. PMCID: PMC7667370. DOI: 10.1002/mgg3.1496.
16 Yang Y, Xu L, Yu Z, et al. Clinical and genetic analysis of ZTTK syndrome caused by SON heterozygous mutation c.394C>T[J]. Mol Genet Genomic Med, 2019, 7(11): e953. PMID: 31557424. PMCID: PMC6825855. DOI: 10.1002/mgg3.953.
17 Yi Z, Song Z, Li F, et al. A novel de novo frameshift variation in the SON gene causing severe global developmental delay and seizures in a Chinese female[J]. Int J Dev Neurosci, 2022, 82(3): 271-276. PMID: 35080253. DOI: 10.1002/jdn.10170.
18 Pietrobattista A, Della Volpe L, Francalanci P, et al. The expanding phenotype of ZTTK syndrome due to the heterozygous variant of SON gene focusing on liver involvement: patient report and literature review[J]. Genes (Basel), 2023, 14(3): 739. PMID: 36981010. PMCID: PMC10048019. DOI: 10.3390/genes14030739.
19 Vasquez-Forero DM, Masotto B, Ferrer-Avargues R, et al. Case report: a novel SON mutation in a Colombian patient with ZTTK syndrome[J]. Front Genet, 2023, 14: 1183362. PMID: 37476413. PMCID: PMC10354630. DOI: 10.3389/fgene.2023.1183362.
20 Pavone P, Saia F, Pappalardo X, et al. Novel malformations: Chiari type 1 and hydrocephalus in Zhu-Tokita-Takenouchi-Kim syndrome and novel SON variants[J]. Clin Case Rep, 2022, 10(12): e6529. PMID: 36540882. PMCID: PMC9755635. DOI: 10.1002/ccr3.6529.
21 Eid M, Bhatia S. Novel de novo heterozygous variants in the SON gene causing ZTTK syndrome: a case report of two patients and review of neurological findings[J]. Child Neurol Open, 2022, 9: 2329048X221119658. PMID: 36387043. PMCID: PMC9661544. DOI: 10.1177/2329048X221119658.
22 贠国俊, 王景刚, 李庆云, 等. SON基因变异致ZTTK综合征1例报告[J]. 临床儿科杂志, 2021, 39(11): 825-828. DOI: 10.3969/j.issn.1000-3606.2021.11.007.
23 赵培伟, 毕博, 张蕾, 等. SON基因异常致ZTTK综合征3例临床及遗传学分析[J]. 临床儿科杂志, 2023, 41(2): 113-116. DOI: 10.12372/jcp.2023.22e0180.
24 Na J, Cui L, Zhen Z, et al. Recurrent myocardial injury in a de novo SON mutation ZTTK syndrome patient: a case report[J]. BMC Pediatr, 2024, 24(1): 232. PMID: 38566089. PMCID: PMC10985872. DOI: 10.1186/s12887-024-04703-4.
25 Kushary ST, Revah-Politi A, Barua S, et al. ZTTK syndrome: clinical and molecular findings of 15 cases and a review of the literature[J]. Am J Med Genet A, 2021, 185(12): 3740-3753. PMID: 34331327. PMCID: PMC8595531. DOI: 10.1002/ajmg.a.62445.
26 Van Stechelman P, Wilson B, Grebe TA, et al. Hypogammaglobulinemia in 2 children with Zhu-Tokita-Takenouchi-Kim syndrome[J]. Ann Allergy Asthma Immunol, 2024, 133(1): 109-110. PMID: 38588913. DOI: 10.1016/j.anai.2024.04.005.
27 Halliday BJ, Baynam G, Ewans L, et al. Distinctive brain malformations in Zhu-Tokita-Takenouchi-Kim syndrome[J]. AJNR Am J Neuroradiol, 2022, 43(11): 1660-1666. PMID: 36229163. PMCID: PMC9731255. DOI: 10.3174/ajnr.A7663.
28 Dingemans AJM, Truijen KMG, Kim JH, et al. Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON[J]. Eur J Hum Genet, 2022, 30(3): 271-281. PMID: 34521999. PMCID: PMC8904542. DOI: 10.1038/s41431-021-00960-4.
29 Vukadin L, Park B, Mohamed M, et al. A mouse model of Zhu-Tokita-Takenouchi-Kim syndrome reveals indispensable SON functions in organ development and hematopoiesis[J]. JCI insight, 2024, 9(5): e175053. PMID: 38290089. PMCID: PMC10972584. DOI: 10.1172/jci.insight.175053.